|
|
Article: A bitter pill: big Pharma seems to be the target du jour of plaintiffs' attorneys. This product liability onslaught might not just be affecting the insurance market, but also the pharmaceutical companies' abilities to produce new, more effective drugs.(RISK & INSURANCE: INDUSTRY RISK REPORT: PHARMACEUTICALS)
- Article from:
- Risk & Insurance
- Article date:
- September 1, 2006
- Author:
CopyrightCOPYRIGHT 2006 Axon Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The global pharmaceutical companies with their deep pockets have been the target for damaging lawsuits and class actions. They've been accused of misleading labeling and the withholding of testing data of certain drugs, of failure to conduct adequate or appropriate clinical trials and exerting unethical pressure on intermediaries before and after the drugs were released to the public. These legal actions have resulted in billions of dollars being paid out to thousands of drug users, as well as millions to plaintiffs' lawyers.
The most current and prominent drug product liability lawsuit has been litigation involving Vioxx, the cox-2 inhibitor painkiller ...